Found 40 results
Author Title [ Type(Desc)] Year
Filters: Author is Lindblad, Robert  [Clear All Filters]
Journal Article
O. D. Jarrett, Seward, J. F., Fombah, A. E., Lindblad, R., Jalloh, M. I., El-Khorazaty, J., Dawson, P., Burton, D., Zucker, J., Carr, W., Bah, M. M., Deen, G. F., George, P. M., James, F., Lisk, D. R., Pratt, D., Russell, J. B. W., Sandy, J. D., Turay, P., Hamel, M. J., Schrag, S. J., Walker, R. E., Samai, M., and Goldstein, S. T., Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola., J Infect Dis, vol. 217, no. suppl_1, pp. S24-S32, 2018.
T. M. Winhusen, Kropp, F., Lindblad, R., Douaihy, A., Haynes, L., Hodgkins, C., Chartier, K., Kampman, K. M., Sharma, G., Lewis, D. F., VanVeldhuisen, P., Theobald, J., May, J., and Brigham, G. S., Multisite, randomized, double-blind, placebo-controlled pilot clinical trial to evaluate the efficacy of buspirone as a relapse-prevention treatment for cocaine dependence., J Clin Psychiatry, vol. 75, no. 7, pp. 757-64, 2014.
U. E. Ghitza, Gore-Langton, R. E., Lindblad, R., and Tai, B., NIDA Clinical Trials Network Common Data Elements Initiative: Advancing Big-Data Addictive-Disorders Research., Front Psychiatry, vol. 6, p. 33, 2015.
J. D. Lee, Nunes, E. V., Mpa, P. Novo, Bailey, G. L., Brigham, G. S., Cohen, A. J., Fishman, M., Ling, W., Lindblad, R., Shmueli-Blumberg, D., Stablein, D., May, J., Salazar, D., Liu, D., and Rotrosen, J., NIDA Clinical Trials Network CTN-0051, Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT): Study design and rationale., Contemp Clin Trials, vol. 50, pp. 253-64, 2016.
B. Tai, Hu, L., Ghitza, U. E., Sparenborg, S., VanVeldhuisen, P., and Lindblad, R., Patient registries for substance use disorders., Subst Abuse Rehabil, vol. 5, pp. 81-6, 2014.
D. M. Donovan, Bigelow, G. E., Brigham, G. S., Carroll, K. M., Cohen, A. J., Gardin, J. G., Hamilton, J. A., Huestis, M. A., Hughes, J. R., Lindblad, R., G Marlatt, A., Preston, K. L., Selzer, J. A., Somoza, E. C., Wakim, P. G., and Wells, E. A., Primary outcome indices in illicit drug dependence treatment research: systematic approach to selection and measurement of drug use end-points in clinical trials., Addiction, vol. 107, no. 4, pp. 694-708, 2012.
R. A. Wood, Kim, J. S., Lindblad, R., Nadeau, K., Henning, A. K., Dawson, P., Plaut, M., and Sampson, H. A., A randomized, double-blind, placebo-controlled study of omalizumab combined with oral immunotherapy for the treatment of cow's milk allergy., J Allergy Clin Immunol, vol. 137, no. 4, pp. 1103-1110.e11, 2016.
B. Tai, Gore-Langton, R. E., Ghitza, U. E., Lindblad, R., Subramaniam, G., and Shide, D., Response to commentaries., Addiction, vol. 108, no. 1, pp. 12-3, 2013.
T. L. Whiteside, Griffin, D. L., Stanson, J., Gooding, W., McKenna, D., Sumstad, D., Kadidlo, D., Gee, A., Durett, A., Lindblad, R., Wood, D., and Styers, D., Shipping of therapeutic somatic cell products., Cytotherapy, vol. 13, no. 2, pp. 201-13, 2011.
M. Samai, Seward, J. F., Goldstein, S. T., Mahon, B. E., Lisk, D. Radcliffe, Widdowson, M. - A., Jalloh, M. I., Schrag, S. J., Idriss, A., Carter, R. J., Dawson, P., Kargbo, S. A. S., Leigh, B., Bawoh, M., Legardy-Williams, J., Deen, G., Carr, W., Callis, A., Lindblad, R., Russell, J. B. W., Petrie, C. R., Fombah, A. E., Kargbo, B., McDonald, W., Jarrett, O. D., Walker, R. E., Gargiullo, P., Bash-Taqi, D., Gibson, L., Fofanah, A. Bakarr, and Schuchat, A., The Sierra Leone Trial to Introduce a Vaccine Against Ebola: An Evaluation of rVSV∆G-ZEBOV-GP Vaccine Tolerability and Safety During the West Africa Ebola Outbreak., J Infect Dis, vol. 217, no. suppl_1, pp. S6-S15, 2018.
R. Lindblad, Campanella, M., Styers, D., Kothari, P., Sparenborg, S., and Rosa, C., Strategies for safety reporting in substance abuse trials., Am J Drug Alcohol Abuse, vol. 37, no. 5, pp. 440-5, 2011.
D. M. Fleischer, A Burks, W., Vickery, B. P., Scurlock, A. M., Wood, R. A., Jones, S. M., Sicherer, S. H., Liu, A. H., Stablein, D., Henning, A. K., Mayer, L., Lindblad, R., Plaut, M., and Sampson, H. A., Sublingual immunotherapy for peanut allergy: a randomized, double-blind, placebo-controlled multicenter trial., J Allergy Clin Immunol, vol. 131, no. 1, pp. 119-27.e1-7, 2013.
W. A Burks, Wood, R. A., Jones, S. M., Sicherer, S. H., Fleischer, D. M., Scurlock, A. M., Vickery, B. P., Liu, A. H., Henning, A. K., Lindblad, R., Dawson, P., Plaut, M., and Sampson, H. A., Sublingual immunotherapy for peanut allergy: Long-term follow-up of a randomized multicenter trial., J Allergy Clin Immunol, vol. 135, no. 5, pp. 1240-8.e1-3, 2015.
Z. Wu, Tang, Z., Mao, Y., Van Veldhuisen, P., Ling, W., Liu, D., Shen, Z., Detels, R., Lan, G., Erinoff, L., Lindblad, R., Gu, D., Tang, H., Hu, L., Zhu, Q., Lu, L., Oden, N., Hasson, A. L., Zhao, Y., McGoogan, J. M., Ge, X., Zhang, N., Rou, K., Zhu, J., Wei, H., Shi, C. X., Jin, X., Li, J., and Montaner, J. S. G., Testing and linkage to HIV care in China: a cluster-randomised trial., Lancet HIV, vol. 4, no. 12, pp. e555-e565, 2017.
L. - T. Wu, Brady, K. T., Spratt, S. E., Dunham, A. A., Heidenfelder, B., Batch, B. C., Lindblad, R., VanVeldhuisen, P., Rusincovitch, S. A., Killeen, T. K., and Ghitza, U. E., Using electronic health record data for substance use Screening, Brief Intervention, and Referral to Treatment among adults with type 2 diabetes: Design of a National Drug Abuse Treatment Clinical Trials Network study., Contemp Clin Trials, vol. 46, pp. 30-38, 2016.